{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:39:53Z","timestamp":1789011593568,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.antiviral.2017.01.011","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T12:32:10Z","timestamp":1485433930000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"140","author":[{"given":"Hyun-Min","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Seob","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Hwan","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-0641","authenticated-orcid":false,"given":"Dong-Gun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.antiviral.2017.01.011_bib1","first-page":"20","article-title":"Varicella-zoster virus infection after hematopoietic stem cell transplantation","volume":"41","author":"Akiyama","year":"2000","journal-title":"Rinsho ketsueki"},{"issue":"6","key":"10.1016\/j.antiviral.2017.01.011_bib2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21152","article-title":"Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Asano-Mori","year":"2008","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.antiviral.2017.01.011_bib3","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1017\/S0950268810003031","article-title":"Dynamics in children and adolescents who experience varicella zoster virus infections after haematopoietic stem cell transplantation: a case-control study","volume":"139","author":"Aytac","year":"2011","journal-title":"Epidemiol. Infect."},{"issue":"7","key":"10.1016\/j.antiviral.2017.01.011_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J.\u00a0Nat. Compr. Canc. Netw."},{"issue":"1","key":"10.1016\/j.antiviral.2017.01.011_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bmt.1705191","article-title":"Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience","volume":"37","author":"Berman","year":"2006","journal-title":"Bone marrow Transplant."},{"issue":"10","key":"10.1016\/j.antiviral.2017.01.011_bib6","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbmt.2014.06.002","article-title":"Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis\u2013the incidence remains high","volume":"20","author":"Blennow","year":"2014","journal-title":"Biol. blood marrow Transplant."},{"issue":"5","key":"10.1016\/j.antiviral.2017.01.011_bib7","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation\u2013a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"issue":"Suppl.\u00a0B","key":"10.1016\/j.antiviral.2017.01.011_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/18.Supplement_B.95","article-title":"Induction of acyclovir-resistant mutants of herpes simplex virus type I in athymic nude mice","volume":"18","author":"Ellis","year":"1986","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.antiviral.2017.01.011_bib9","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.antiviral.2017.01.011_bib10","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1086\/342963","article-title":"Varicella-zoster virus: atypical presentations and unusual complications","volume":"186","author":"Gnann","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"issue":"7","key":"10.1016\/j.antiviral.2017.01.011_bib11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bmt.1703214","article-title":"Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Kanda","year":"2001","journal-title":"Bone marrow Transplant."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.antiviral.2017.01.011_bib12","first-page":"73","article-title":"Herpesvirus infections in hematological diseases","volume":"64","author":"Karasuno","year":"2006","journal-title":"Nihon rinsho."},{"issue":"2","key":"10.1016\/j.antiviral.2017.01.011_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12185-015-1810-4","article-title":"Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation","volume":"102","author":"Kawamura","year":"2015","journal-title":"Int. J. Hematol."},{"issue":"6","key":"10.1016\/j.antiviral.2017.01.011_bib14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1399-0012.2008.00877.x","article-title":"Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation","volume":"22","author":"Kim","year":"2008","journal-title":"Clin. Transplant."},{"issue":"2","key":"10.1016\/j.antiviral.2017.01.011_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1399-3062.2007.00247.x","article-title":"Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders","volume":"10","author":"Kim","year":"2008","journal-title":"Transpl. Infect. Dis."},{"issue":"4","key":"10.1016\/j.antiviral.2017.01.011_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J.\u00a0Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.antiviral.2017.01.011_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/bmt.2010.99","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT","volume":"46","author":"Klein","year":"2011","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.antiviral.2017.01.011_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome","volume":"6","author":"Koc","year":"2000","journal-title":"Biol. blood marrow Transplant."},{"issue":"4","key":"10.1016\/j.antiviral.2017.01.011_bib19","first-page":"444","article-title":"Clinical characteristics of and risk factors for herpes zoster after hematopoietic stem cell transplantation","volume":"87","author":"Leung","year":"2002","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.antiviral.2017.01.011_bib20","first-page":"44","article-title":"The clinical features of infection in multiple myeloma undergoing autologous hematopoietic stem cell transplantation","volume":"50","author":"Li","year":"2011","journal-title":"Zhonghua nei ke za zhi"},{"issue":"4","key":"10.1016\/j.antiviral.2017.01.011_bib21","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.antiviral.2017.01.011_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"18","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.antiviral.2017.01.011_bib23","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1086\/320157","article-title":"A\u00a0predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation","volume":"32","author":"Offidani","year":"2001","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis."},{"issue":"12","key":"10.1016\/j.antiviral.2017.01.011_bib24","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1128\/JCM.01312-06","article-title":"Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients","volume":"44","author":"Onozawa","year":"2006","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.antiviral.2017.01.011_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1399-3062.2010.00541.x","article-title":"One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group","volume":"12","author":"Oshima","year":"2010","journal-title":"Transpl. Infect. Dis."},{"issue":"9","key":"10.1016\/j.antiviral.2017.01.011_bib26","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.bbmt.2012.02.008","article-title":"Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients","volume":"18","author":"Pergam","year":"2012","journal-title":"Biol. blood marrow Transplant."},{"issue":"5","key":"10.1016\/j.antiviral.2017.01.011_bib27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-3062.2011.00655.x","article-title":"Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population","volume":"13","author":"Rogers","year":"2011","journal-title":"Transpl. Infect. Dis."},{"issue":"4","key":"10.1016\/j.antiviral.2017.01.011_bib28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","article-title":"Herpes zoster infection after autologous bone marrow transplantation","volume":"74","author":"Schuchter","year":"1989","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.antiviral.2017.01.011_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1989.88","article-title":"The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation","volume":"59","author":"Selby","year":"1989","journal-title":"Br. J. cancer"},{"issue":"1","key":"10.1016\/j.antiviral.2017.01.011_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/tid.12165","article-title":"Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience","volume":"16","author":"Srinivasan","year":"2014","journal-title":"Transpl. Infect. Dis."},{"issue":"6","key":"10.1016\/j.antiviral.2017.01.011_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1702190","article-title":"Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir","volume":"25","author":"Steer","year":"2000","journal-title":"Bone marrow Transplant."},{"issue":"15","key":"10.1016\/j.antiviral.2017.01.011_bib32","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.antiviral.2017.01.011_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.achaem.2015.03.004","article-title":"Viral infections in children undergoing hematopoietic stem cell transplantation","volume":"46","author":"Styczy\u0144ski","year":"2015","journal-title":"Acta Haematol. Pol."},{"issue":"7","key":"10.1016\/j.antiviral.2017.01.011_bib34","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbmt.2010.10.025","article-title":"High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation","volume":"17","author":"Su","year":"2011","journal-title":"Biol. blood marrow Transplant."},{"issue":"2","key":"10.1016\/j.antiviral.2017.01.011_bib35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2141.2012.09170.x","article-title":"Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort","volume":"158","author":"Toze","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.antiviral.2017.01.011_bib36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-013-1913-z","article-title":"Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients","volume":"93","author":"Truong","year":"2014","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.antiviral.2017.01.011_bib37","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/j.ijid.2009.06.007","article-title":"Low-dose acyclovir against reactivation of varicella zoster virus after unrelated cord blood transplantation","volume":"14","author":"Uchiyama","year":"2010","journal-title":"Int. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2017.01.011_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/cid\/cis879","article-title":"Persistence and antiviral resistance of varicella zoster virus in hematological patients","volume":"56","author":"van der Beek","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2017.01.011_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/bmt.2010.52","article-title":"Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience","volume":"46","author":"Verdeguer","year":"2011","journal-title":"Bone Marrow Transplant."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T18:38:03Z","timestamp":1601491083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216307458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":39,"alternative-id":["S0166354216307458"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}